Laekna, Inc. (2105.HK) has a MoatMap StockRank of 17/100 based on Quality (34/100), Value (37/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL. Laekna, Inc., a Chinese healthcare company, faces significant headwinds from the 'Flight to Safe Havens & EM De-risking' macro theme, which signals capital outflows and caution towards emerging markets. As an emerging market equity with a 'STRONG_SELL' signal, it fails to meet the criteria for a quality compounder or a reasonable-price investment, especially with macro tailwinds working against it.